Drugs News and Research

RSS

Leaves of the Labrador tea plant contain an essential oil that could help combat malaria

Much of what is now considered modern medicine originated as folk remedies or traditional, Indigenous practices. These customs are still alive today, and they could help address a variety of conditions.

11 May 2023

PBMs, the brokers who control drug prices, finally get Washington’s attention

For two decades, patients and physicians eagerly awaited a lower-cost version of the world's bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of more than 250 patents around it.

11 May 2023

New tool launched to make ESMO Clinical Practice Guidelines easier to use in routine clinical practice

ESMO, the leading professional organization for medical oncology, today announced the launch of a new tool designed to make the renowned ESMO Clinical Practice Guidelines (CPGs) easier to use in oncologists' routine clinical practice and support optimal decision-making in a rapidly evolving medical field.

10 May 2023

New advanced AI system shows accuracy and speed in identifying protein patterns

A new advanced artificial intelligence (AI) system has shown world-leading accuracy and speed in identifying protein patterns within individual cells.

10 May 2023

Cardiovascular risk reduction in type 2 diabetes: Study urges better use of life-saving therapies

Researchers explore the efficacy of current approaches to reduce the risk of cardiovascular events in patients with type 2 diabetes.

10 May 2023

Rising tide of chronic disease can be traced to impaired salugenesis, incomplete healing

In medicine and science, the term "pathogenesis" describes the origin and development of disease. There is not, however, a broadly accepted term to describe the other half of the equation: the process of healing and recovery.

10 May 2023

Schlafen 12 identified as a novel HIV restriction factor

An international study led by MELIS-UPF researchers from the Infection Biology and Molecular Virology laboratories has identified and characterized Schlafen 12 (SLFN 12) as a novel HIV restriction factor.

10 May 2023

California confronts overdose epidemic among former prison inmates

Michael Vera walked into a bedroom of a residential drug treatment program in Los Angeles in March to find its occupant slumped over on his bed and struggling to breathe, a homemade straw on the floor beside him and tinfoil with what appeared to be drug residue under his body.

10 May 2023

An outdated tracking system is a key factor in Texas’ foster care shortcomings

The decades-old system Texas foster care officials use to track and monitor the health records of the nearly 20,000 children in their custody is both outdated and unreliable — so much so, advocates say, that children have been harmed or put at risk.

10 May 2023

Researchers map the immune system in the gut of kids with inflammatory bowel disease

Researchers from Karolinska Institutet and Sachs' Children and Youth Hospital in Sweden have mapped the immune system in the gut of children with inflammatory bowel disease (IBD).

9 May 2023

Study shows the power of gamma enhancement as potential approach for countering depression

Led by researchers from NYU Grossman School of Medicine and Hungary's University of Szeged, a new study in mice and rats found that restoring certain signals in a brain region that processes smells countered depression.

9 May 2023

Different statin drugs exert different effects on COVID-19 patients

We've all recently gotten a crash-course in drug repurposing, thanks to near-daily news reports about efforts to identify existing medicines that could help treat COVID-19 in the early phase of the pandemic.

9 May 2023

New AI tool shows early promise in detecting Parkinson's disease years before symptom onset

Scientists from UNSW Sydney with collaborators at Boston University have developed a tool that shows early promise in detecting Parkinson's disease years before the first symptoms start appearing.

9 May 2023

Most effective treatment for excessive daytime sleepiness found

McMaster University researchers Dena Zeraatkar and Tyler Pitre have found that the drug solriamfetol is the most effective treatment for excessive daytime sleepiness (EDS) for people with obstructive sleep apnea (OSA).

9 May 2023

Ultra-long protein fibrils are a signature of severe Alzheimer’s disease, study shows

During the course of Alzheimer's disease, protein fibrils appear in the spinal fluid of affected individuals. Empa researchers, together with the Department of Neurology at the Cantonal Hospital in St. Gallen, have now visualized the wide spectrum of protein aggregates from oligomers, protofibrils to fibrils in the spinal fluid.

9 May 2023

Drugs News and Research

Leaves of the Labrador tea plant contain an essential oil that could help combat malaria

PBMs, the brokers who control drug prices, finally get Washington’s attention

New tool launched to make ESMO Clinical Practice Guidelines easier to use in routine clinical practice

New advanced AI system shows accuracy and speed in identifying protein patterns

Cardiovascular risk reduction in type 2 diabetes: Study urges better use of life-saving therapies

Rising tide of chronic disease can be traced to impaired salugenesis, incomplete healing

Schlafen 12 identified as a novel HIV restriction factor

California confronts overdose epidemic among former prison inmates

An outdated tracking system is a key factor in Texas’ foster care shortcomings

Researchers map the immune system in the gut of kids with inflammatory bowel disease

Study shows the power of gamma enhancement as potential approach for countering depression

Different statin drugs exert different effects on COVID-19 patients

New AI tool shows early promise in detecting Parkinson's disease years before symptom onset

Most effective treatment for excessive daytime sleepiness found

Ultra-long protein fibrils are a signature of severe Alzheimer’s disease, study shows

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

Study: Spike in the price of gout drug colchicine linked to lower use and worse disease control

Legal pot is more potent than ever — and still largely unregulated

Understanding Lupus: an interview with the Garvan Institute

Multiscale modeling and personalized therapies: tackling the complexities of epilepsy with degeneracy concept

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News